GB1539473A - N-aryl-n-(1-l-4-piperidinyl)-arylacetamides - Google Patents

N-aryl-n-(1-l-4-piperidinyl)-arylacetamides

Info

Publication number
GB1539473A
GB1539473A GB39099/76A GB3909976A GB1539473A GB 1539473 A GB1539473 A GB 1539473A GB 39099/76 A GB39099/76 A GB 39099/76A GB 3909976 A GB3909976 A GB 3909976A GB 1539473 A GB1539473 A GB 1539473A
Authority
GB
United Kingdom
Prior art keywords
arylacetamides
piperidinyl
aryl
formula
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39099/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of GB1539473A publication Critical patent/GB1539473A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB39099/76A 1975-09-23 1976-09-21 N-aryl-n-(1-l-4-piperidinyl)-arylacetamides Expired GB1539473A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
GB1539473A true GB1539473A (en) 1979-01-31

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
GB39099/76A Expired GB1539473A (en) 1975-09-23 1976-09-21 N-aryl-n-(1-l-4-piperidinyl)-arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (fr)
AT (1) AT363935B (fr)
AU (1) AU510029B2 (fr)
BG (1) BG27543A3 (fr)
CA (1) CA1068271A (fr)
CH (1) CH628623A5 (fr)
CS (1) CS222663B2 (fr)
DE (1) DE2642856A1 (fr)
DK (1) DK150478C (fr)
ES (1) ES451768A1 (fr)
FI (1) FI61482C (fr)
FR (1) FR2325377A1 (fr)
GB (1) GB1539473A (fr)
GR (1) GR58469B (fr)
HU (1) HU172964B (fr)
IE (1) IE43802B1 (fr)
IL (1) IL50522A (fr)
IT (1) IT1073893B (fr)
LU (1) LU75837A1 (fr)
NL (1) NL187267C (fr)
NO (1) NO147672C (fr)
NZ (1) NZ181972A (fr)
PH (1) PH12497A (fr)
PL (2) PL117323B1 (fr)
PT (1) PT65631B (fr)
RO (1) RO70079A (fr)
SE (1) SE427839B (fr)
SU (1) SU747424A3 (fr)
YU (1) YU39973B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791120B2 (en) 2007-02-13 2014-07-29 Janssen Pharmaceutica Nv Fast-dissociating dopamine 2 receptor antagonists
US8895562B2 (en) 2008-07-31 2014-11-25 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
US8906921B2 (en) 2007-04-23 2014-12-09 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
US8933101B2 (en) 2007-04-23 2015-01-13 Janssen Pharmaceutica Nv Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
US8940743B2 (en) 2005-10-26 2015-01-27 Janssen Pharmaceutica Nv Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh) 2008-07-03 2014-09-24 詹森药业有限公司 作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8940743B2 (en) 2005-10-26 2015-01-27 Janssen Pharmaceutica Nv Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
US9468640B2 (en) 2005-10-26 2016-10-18 Janssen Pharmaceutica Nv Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
US9751860B2 (en) 2005-10-26 2017-09-05 Janssen Pharmaceutica Nv Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
US8791120B2 (en) 2007-02-13 2014-07-29 Janssen Pharmaceutica Nv Fast-dissociating dopamine 2 receptor antagonists
US9422296B2 (en) 2007-02-13 2016-08-23 Janssen Pharmaceutica Nv Fast-dissociating dopamine 2 receptor antagonists
US8906921B2 (en) 2007-04-23 2014-12-09 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
US8933101B2 (en) 2007-04-23 2015-01-13 Janssen Pharmaceutica Nv Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
US8895562B2 (en) 2008-07-31 2014-11-25 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (fr) 1980-04-18
HU172964B (hu) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (fr) 1982-10-26
LU75837A1 (fr) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (fi) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (fr) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
FI762698A (fr) 1977-03-24
NO763054L (no) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (ru) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (nl) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (fr) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (it) 1985-04-17
PT65631A (en) 1976-10-01
ATA702976A (de) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
DK427876A (da) 1977-03-24
NL187267C (nl) 1991-08-01
DE2642856A1 (de) 1977-03-24
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (no) 1983-02-14
AT363935B (de) 1981-09-10

Similar Documents

Publication Publication Date Title
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
SE7703842L (sv) Nya piperazin- och piperinderivat
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
ES453309A1 (es) Un procedimiento de preparacion de derivados de acidos dife-noxi-2-alcanocarboxilicos.
GB1539473A (en) N-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE7514271L (sv) Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat
GB1542514A (en) 1-(benzazolylalkyl)piperidine derivatives
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
GB1492528A (en) Pyrazinyl piperazine derivatives
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
GB1471847A (en) Dibenzofuran derivatives
ES414955A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
SU674671A3 (ru) Способ получени производных пирролидина
SE7508793L (sv) Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav
CH611602A5 (en) Process for the preparation of (N-ethyl-2-pyrrolidino)methylamine derivatives
SE7612961L (sv) Tienamycinderivat
ES454280A1 (es) Procedimiento para preparar 1-(2-(beta-naftiloxi)-etil)-3-metilpirazolona-(5).
ES398080A1 (es) Procedimiento para la preparacion de derivados de 1-vinil- carbonil-piperazina.
BG35040A3 (en) Method for preparing a benzoimic derivative of 2- (2, 6'- dichlorphenylamino)- 2- imidazoline and its salt
FR2315932A1 (fr) Derives d'acides quinoleine-carboxyliques et medicaments qui en contiennent
SE412907B (sv) Forfarande for framstellning av nya n-2'-karboxifenyl-4-klorantranilsyror
FR2290203A1 (fr) 10,11-dihydro-3-carboxycyproheptadine et son n-oxyde
ES403886A1 (es) Procedimiento de preparacion de amidas del acido (trimetoxi-3,4,5)cinemico.
ES455692A1 (es) Procedimiento para la produccion de derivados de alquilen- dioxipiperacina.
ES461846A2 (es) Un procedimiento para la preparacion de acidos carboxilicos alfa-cetonicos.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PCNP Patent ceased through non-payment of renewal fee